ITUS CORPORATION (NASDAQ:ITUS) Files An 8-K Other EventsItem 8.01 Other Events
On March 5, 2018, ITUS Corporation issued a press release announcing the formation of a strategic alliance with Serametrix Corporation. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are filed with this Current Report on Form 8-K:
Exhibit No. Description
99.1 Press Release dated March 5, 2018
ITUS Corp ExhibitEX-99.1 2 Exhibit99_1.htm EXHIBIT 99.1 Exhibit 99.1 Exhibit 99.1 ITUS Corporation Forms Alliance with Serametrix Corporation SAN JOSE,…To view the full exhibit click here
About ITUS CORPORATION (NASDAQ:ITUS)
ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient’s immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. Instead of seeking to alter or boost the body’s immune system and its ability to destroy cancer cells, the Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients.
